We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
UDR
UDR
$12.2B
| $8.74M | 0.04% |
+305,181
| New | +$8.22M |
|
|
CSGS
327
DELISTED
CSG Systems International
CSGS
| $8.73M | 0.04% |
334,243
+11,205
| +3% | +$291K |
|
|
CHA
328
DELISTED
China Telecom Corporation, LTD
CHA
| $8.63M | 0.04% |
176,320
-42,371
| -19% | -$2.07M |
|
329
IQVIA
IQV
$38B
| $8.59M | 0.04% |
161,121
-132,488
| -45% | -$6.69M |
|
|
CPHD
330
DELISTED
Cepheid Inc
CPHD
| $8.42M | 0.04% |
175,623
-190,792
| -52% | -$8.65M |
|
|
TECD
331
DELISTED
Tech Data Corp
TECD
| $8.25M | 0.04% |
131,978
+40,117
| +44% | +$2.49M |
|
332
Insulet
PODD
$9.59B
| $8.17M | 0.04% |
205,936
+51,313
| +33% | +$1.97M |
|
|
HRG
333
DELISTED
HRG Group, Inc.
HRG
| $8.15M | 0.04% |
641,512
-93,322
| -13% | -$1.12M |
|
|
TXNM
334
TXNM Energy Inc
TXNM
$5.92B
| $8.14M | 0.04% |
277,489
+90,033
| +48% | +$2.52M |
|
|
AF
335
DELISTED
Astoria Financial Corporation
AF
| $8.11M | 0.04% |
602,613
-69,150
| -10% | -$918K |
|
336
Comscore
SCOR
$112M
| $8.1M | 0.04% |
11,413
-5,661
| -33% | -$3.64M |
|
337
TJX Companies
TJX
$178B
| $7.95M | 0.04% |
+298,962
| New | +$8.53M |
|
338
Encompass Health
EHC
$12.4B
| $7.93M | 0.04% |
277,931
-44,594
| -14% | -$1.24M |
|
339
AES
AES
$10.5B
| $7.89M | 0.04% |
507,142
-217,767
| -30% | -$3.13M |
|
340
Burlington
BURL
$23.3B
| $7.87M | 0.04% |
246,960
+103,205
| +72% | +$2.99M |
|
|
MASI
341
DELISTED
Masimo
MASI
| $7.83M | 0.04% |
331,568
+180,228
| +119% | +$4.47M |
|
|
PLCM
342
DELISTED
POLYCOM INC
PLCM
| $7.72M | 0.04% |
616,193
+70,711
| +13% | +$897K |
|
343
Kulicke & Soffa
KLIC
$4.7B
| $7.66M | 0.04% |
537,213
-274,366
| -34% | -$3.76M |
|
344
White Mountains Insurance
WTM
$5.28B
| $7.65M | 0.04% |
12,570
+3,042
| +32% | +$1.81M |
|
345
Intuit
INTU
$87.9B
| $7.56M | 0.04% |
93,924
+26,873
| +40% | +$2.07M |
|
|
CVC
346
DELISTED
CABLEVISION SYS CP NY GRP CL-A
CVC
| $7.56M | 0.04% |
428,269
+56,296
| +15% | +$962K |
|
347
Harley-Davidson
HOG
$2.7B
| $7.55M | 0.04% |
+108,135
| New | +$7.62M |
|
|
MDCO
348
DELISTED
Medicines Co
MDCO
| $7.52M | 0.04% |
258,887
-223,469
| -46% | -$5.97M |
|
|
ELP
349
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $7.5M | 0.04% |
1,224,808
+1,095,200
| +845% | +$6.47M |
|
|
WPG
350
DELISTED
Washington Prime Group Inc.
WPG
| $7.46M | 0.04% |
+44,257
| New | +$7.7M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.